Amelioration of NAFLD was associated with suppression of hepatic DNL, whereas improved glucose metabolism appeared to result from suppression of both hepatic gluconeogenesis and FAO, with these latter effects being mediated by different mechanisms in Mc4r-KO and leptin-deficient mice. Here, MC4R is linked to metabolic dysfunction-associated steatotic liver disease.